SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-14-394306
Filing Date
2014-11-03
Accepted
2014-11-03 17:24:05
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d811394ds3.htm S-3 312832
2 EX-1.1 d811394dex11.htm EX-1.1 178691
3 EX-5.1 d811394dex51.htm EX-5.1 9454
4 EX-23.2 d811394dex232.htm EX-23.2 1346
5 GRAPHIC g811394g05x07.jpg GRAPHIC 15049
6 GRAPHIC g811394g55l03.jpg GRAPHIC 21048
7 GRAPHIC g811394g56e30.jpg GRAPHIC 18862
  Complete submission text file 0001193125-14-394306.txt   579524
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-199821 | Film No.: 141190393
SIC: 2836 Biological Products, (No Diagnostic Substances)